Upon a nutrient challenge, L cells produce glucagon-like peptide 1 (GLP-1), a powerful stimulant of insulin release. Strategies to augment endogenous GLP-1 production include promoting L-cell differentiation and increasing L-cell number. Here we present a novel in vitro platform to generate functional L cells from three-dimensional cultures of mouse and human intestinal crypts. We show that short-chain fatty acids selectively increase the number of L cells, resulting in an elevation of GLP-1 release. This is accompanied by the upregulation of transcription factors associated with the endocrine lineage of intestinal stem cell development. Thus, our platform allows us to study and modulate the development of L cells in mouse and human crypts ...
As a highly regenerative organ, the intestine is a promising source for cellular reprogramming for r...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2 diabetes, and t...
Upon a nutrient challenge, L cells produce glucagon-like peptide 1 (GLP-1), a powerful stimulant of ...
[Aims/Introduction]Glucagon-like peptide-1 (GLP-1) secreted from enteroendocrine L cells is an incre...
UNLABELLED: Glucagon-like peptide-1 (GLP-1) acts as a satiety signal and enhances insulin release. T...
AbstractGlucagon-like peptide-1 (GLP-1) acts as a satiety signal and enhances insulin release. This ...
Enteroendocrine cells (EECs) are chemosensitive cells of the gastrointestinal epithelium that exert ...
SummaryThe ability to interconvert terminally differentiated cells could serve as a powerful tool fo...
Transgenic mice carrying the human insulin gene driven by the K-cell glucose-dependent insulinotropi...
Intestinal organoids are used to analyze the differentiation of enteroendocrine cells (EECs) and to ...
SummaryGlucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and i...
Targeting L-cell development and enrichment of incretin-secreting cells could potentially evolve as ...
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2 diabetes, and t...
[[abstract]]©2003 Elsevier - Cell-based therapies for treating insulin-dependent diabetes (IDD) can ...
As a highly regenerative organ, the intestine is a promising source for cellular reprogramming for r...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2 diabetes, and t...
Upon a nutrient challenge, L cells produce glucagon-like peptide 1 (GLP-1), a powerful stimulant of ...
[Aims/Introduction]Glucagon-like peptide-1 (GLP-1) secreted from enteroendocrine L cells is an incre...
UNLABELLED: Glucagon-like peptide-1 (GLP-1) acts as a satiety signal and enhances insulin release. T...
AbstractGlucagon-like peptide-1 (GLP-1) acts as a satiety signal and enhances insulin release. This ...
Enteroendocrine cells (EECs) are chemosensitive cells of the gastrointestinal epithelium that exert ...
SummaryThe ability to interconvert terminally differentiated cells could serve as a powerful tool fo...
Transgenic mice carrying the human insulin gene driven by the K-cell glucose-dependent insulinotropi...
Intestinal organoids are used to analyze the differentiation of enteroendocrine cells (EECs) and to ...
SummaryGlucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and i...
Targeting L-cell development and enrichment of incretin-secreting cells could potentially evolve as ...
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2 diabetes, and t...
[[abstract]]©2003 Elsevier - Cell-based therapies for treating insulin-dependent diabetes (IDD) can ...
As a highly regenerative organ, the intestine is a promising source for cellular reprogramming for r...
GLP-1 (glucagon-like peptide-1) is a potent insulin secretagogue released from L cells in the intest...
Glucagon-like peptide 1 (GLP-1) mimetics are effective drugs for treatment of type 2 diabetes, and t...